The deal comes at a time when the Anglo-Swedish pharma company is facing a string of investigations in the country, ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback